Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of grape-like organoids and others in iPSC derived Hepatocyte organoids (iHOs)

ABSTRACT: RNA-seq analysis of grape-like organoids and others in iPSC derived Hepatocyte organoids (iHOs)

PROVIDER: PRJNA1203632 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31840165_1.fastq.gz	Fastqsanger.gz
	SRR31840165_2.fastq.gz	Fastqsanger.gz
	SRR31840166_1.fastq.gz	Fastqsanger.gz
	SRR31840166_2.fastq.gz	Fastqsanger.gz
	SRR31840167_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Comprehensive gene expression analysis of grape-like and other morphologically different organoids in iPSC derived hepatocyte organoids(iHOs).

Project description:iHOs contain morphologically different organoids. Comprehensive gene expression analysis showed grape-like organoids have hepatocyte-like gene expression profiles.

2024-11-18 | GSE248439 | GEO

RNA-seq analysis of grape-like organoids and others in iPSC derived Hepatocyte organoids (iHOs)

Project description:Under iHO conditions, distinctive grape-like organoids emerge. To evaluate the hepatocyte characteristics of grape-like organoids and other organoid forms, grape-like organoids were isolated under a microscope, and RNA-seq was performed.

2025-05-13 | GSE285436 | GEO

scRNA-seq analysis of human iPSC derived Hepatocyte organoids (iHOs) [scRNA-seq]

Project description:Liver has abundant regenerative capacity, but hepatocytes cannot be cultured long-term in vitro. Activation of FXR signaling induced iHOs with both hepatocyte traits and proliferative potential. To investigate the transcriptomic analysis of iHOs, we performed bulk RNA-seq analysis of organoids in different passages and single cell RNA-seq analysis of iHOs. Compared to 2D-iPS-Heps and organoids in other culture conditions, iHOs have expression profiles more similar to primary human hepatocytes and human fetal liver cells. Single cell RNA-seq revealed iHOs have a fraction that co-expresses hepatocyte markers and proliferation markers.

2025-05-13 | GSE247961 | GEO

RNA-seq analysis of human iPSC derived Hepatocyte organoids (iHOs), 2D-iPS-Heps, iPS-HPCs, iPSCs, and other iPSC derived organoids cultured in woBA medium and fetal organoid medium

2025-05-13 | GSE248110 | GEO

Comprehensive gene expression analysis of grape-like and other morphologically different organoids in iPSC derived hepatocyte organoids(iHOs).

Project description:Comprehensive gene expression analysis of grape-like and other morphologically different organoids in iPSC derived hepatocyte organoids(iHOs).

| PRJNA1044013 | ENA

RNA Sequencing of Human iPSC-Derived Hepatocyte Organoids (iHOs)

Project description:RNA Sequencing of Human iPSC-Derived Hepatocyte Organoids (iHOs)

| PRJNA1041782 | ENA

scRNA-seq analysis of human iPSC derived Hepatocyte organoids (iHOs) [scRNA-seq]

Project description:scRNA-seq analysis of human iPSC derived Hepatocyte organoids (iHOs) [scRNA-seq]

| PRJNA1041311 | ENA

RNA-seq analysis of SHP inducible human iPSC derived Hepatocyte organoids (iHOs)

Project description:RNA-seq analysis of SHP inducible human iPSC derived Hepatocyte organoids (iHOs)

| PRJNA1041305 | ENA

RNA-seq analysis of SHP inducible human iPSC derived Hepatocyte organoids (iHOs)

Project description:To investigate the function of small heterodimer partner (SHP) in hepatocytes, we established Dox-inducible SHP overexpression iPSC cell lines and differentiated hepatocytes and cultured iPS-hepatocyte organoids (iHO). A comprehensive RNA-seq analysis was conducted. performed comparative gene expression analysis using data obtained from iHO vehicle and iHO dox.

2025-05-13 | GSE247960 | GEO

Two-dimensionally cultured functional hepatocytes generated from human induced pluripotent stem cell-derived hepatic organoids for pharmaceutical research

Project description:Human induced pluripotent stem (iPS) cell-derived hepatocyte-like cells (HLCs) are expected to replace primary human hepatocytes (PHHs) as a new stable source of hepatocytes for pharmaceutical researches. However, HLCs have lower hepatic functions than PHHs, take a long time to be differentiated and cannot be prepared in large quantities due to not proliferating after their terminal differentiation. To overcome these problems, we have established hepatic organoids (iHOs) from HLCs. The iHOs could proliferate approximately 10^20-fold by more than 10 passages and expressed most hepatic genes higher than HLCs. Furthermore, in order to enable the widespread use of iHOs for in vitro drug discovery research, we have developed the two-dimensional culture protcol for them. Two-dimensional cutured iHOs (2D-iHOs) expressed most of major hepatocyte marker genes and proteins much higher than HLC, iHOs, and even PHHs. The 2D-iHOs had glycogen storage capacity, the capacity to uptake and release indocyanine green (ICG), albumin and urea secretion, and the capacity of bile canaliculi formation. Importantly, the 2D-iHOs had the activity of major drug-metabolizing enzymes and responded to hepatotoxic drugs, comparable to PHHs. Thus, 2D-iHOs overcome the limitation of the current models and promise to provide robust and reproducible pharmaceutical assays.

2025-01-01 | GSE243384 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data